August 7, 2025
The MMA has launched “The One Big Beautiful Bill Act (OBBBA) Resource Guide for Physicians” to help Minnesota practitioners understand how key provisions of the law will affect their practice and patients.
August 7, 2025
Fifty years ago, Minnesota became the first state to adopt legislation restricting smoking in indoor public places and workspaces. That legislation, the Minnesota Clean Indoor Air Act (MCIAA), which the MMA championed, protects workers and the public from the harmful effects of breathing secondhand smoke.
August 7, 2025
The Minnesota Department of Health (MDH) has released a comprehensive Suicide Prevention Awareness Toolkit, designed to help individuals and organizations engage in meaningful conversations, spread awareness, and take action. September is Suicide Prevention Awareness Month.
August 7, 2025
The AMA, along with several other physician advocacy groups, were informed by the Advisory Committee on Immunization Practices (ACIP) on July 31 that their physician experts will no longer be included in the process of reviewing scientific evidence and informing vaccine recommendations, as has long been the case.
July 31, 2025
The MMA has signed on to an AMA letter opposing HR 3164, the “Ensuring Community Access to Pharmacist Services (ECAPS) Act,” in particular because it would allow “pharmacists to perform services that would normally only be authorized and covered if they were furnished by a physician.”
July 31, 2025
Nearly 140,000 Minnesotans will lose their healthcare coverage as a result of President Trump’s budget reconciliation bill, according to a preliminary analysis by the Minnesota Department of Human Services (DHS).
July 31, 2025
MMA members are encouraged to cast their vote for MMA’s future leaders as part of the annual MMA leadership election taking place August 1-31.
July 31, 2025
The Minnesota Department of Health (MDH) has launched a new webpage that includes educational resources on cannabis.
July 31, 2025
The next MMA Physician Forum will be held on Wednesday, September 10, from noon to 1 pm on “Increasing Access to Medications for Opioid Use Disorder (MOUD) in Jails.”
July 31, 2025
Physicians who see patients with syphilis should note that there is a voluntary recall of specific lots of Bicillin® L-A (Penicillin G Benzathine Injectable Suspension) by King Pharmaceuticals LLC., a subsidiary of Pfizer.
